RARE AS ONE
"RARE AS ONE" is a word mark owned by Chan Zuckerberg Initiative, LLC, filed at the USPTO on September 1, 2026. It is under examination and covers classes 9, 16, 35, 36, 41, 42 and 45.
- Status
- Under examination
- Since September 1, 2026
- Filed
- September 1, 2026
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 50084749
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 7 classes
Who owns RARE AS ONE
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Chan Zuckerberg Initiative, LLC
Redwood City, United States
Representative
Anthony Malutta
Kilpatrick Townsend & Stockton LLP
What the mark covers
The products and services RARE AS ONE is filed for, grouped by Nice class.
Downloadable computer software for rare disease research; downloadable computer software for connecting, supporting, and sharing information with patient-led organizations, patient advocacy organizations, researchers, clinicians, industry partners, patients, caregivers, families, academic institutions, healthcare institutions, and community members to improve the lives of people affected by rare disease; downloadable project management software in the field of rare diseases; downloadable computer software for creating searchable databases of information and data; downloadable computer software for database management; downloadable software development tools for database management; downloadable databases in the field of rare diseases; downloadable open-source computer software for use in rare disease research; downloadable computer software using artificial intelligence (AI) for machine learning; downloadable computer software using machine learning for creating data models; downloadable computer software using machine learning for developing predictive models; downloadable computer software for collecting, analyzing and organizing data in the field of deep learning; downloadable electronic publications in the nature of impact reports, news articles, press releases, blogs, and stories in the field of rare diseases
Printed posters; drafting templates; printed educational publications, namely, educational posters, toolkits and templates in the field of rare diseases
Promoting collaboration between patient-led organizations, patient advocacy organizations, researchers, clinicians, industry partners, patients, caregivers, families, academic institutions, healthcare institutions, and other community members to achieve advances in the field of rare diseases; promoting the exchange of information and resources between patient-led organizations, patient advocacy organizations, researchers, clinicians, industry partners, patients, caregivers, families, academic institutions, healthcare institutions, and other community members to achieve advances in the field of rare diseases; promoting public awareness of rare diseases by means of public advocacy; promoting technical and scientific investigation, research and experimentation in the field of scientific discovery through support of educational institutions, scientific organizations, and patient-led organizations; administration of a program to promote treatments and cures for rare diseases; business project management services, namely, developing and coordinating projects between patient-led organizations, patient advocacy organizations, researchers, clinicians, industry partners, patients, caregivers, families, academic institutions, healthcare institutions, and other community members; business services, namely, assisting others in the establishment of charitable organizations; providing business advice and information in the field of rare diseases; internship placement services; administration and management of research grants; charitable services, namely, organizing and developing programs that aim to improve the lives of people affected by rare disease; charitable services, namely, uniting and supporting patient-led organizations, patient advocacy organizations, researchers, clinicians, industry partners, patients, caregivers, families, academic institutions, healthcare institutions, and other community members, working to improve the lives of people affected by rare disease; philanthropic services concerning monetary donations to improve the lives of people affected by rare disease; business consultancy relating to regulatory compliance; regulatory submission management, namely, assisting others in preparing and filing applications for research grants with governmental regulatory bodies; providing public policy information in the field of rare diseases; public policy consultancy in the field of rare diseases; connecting patient communities with researchers
Providing grants to others for projects in the field of rare diseases; financing services; capital investment services; philanthropic services, namely, providing investment management services to support advancements in the field of rare diseases; philanthropic services, namely, financial endowment of efforts to cure rare diseases; charitable foundation services, namely, providing financial support to patient-led organizations, patient advocacy organizations, researchers, clinicians, industry partners, patients, caregivers, families, academic institutions, healthcare institutions, and other community members for developing and launching collaborative research networks in partnership with clinicians and scientists
Education services, namely, providing conferences, symposiums, seminars, classes, workshops, meetings, sessions, webinars, internships, mentoring, and peer learning in the field of rare diseases; educational services, namely, developing curriculum for others in the field of capacity-building for nonprofits; providing online non-downloadable electronic publications in the nature of publications and articles in the field of rare diseases; organizing, designing, and conducting a natural history study; publication of on-line impact reports, news articles, press releases, blogs, and stories; publication of printed matter; multimedia entertainment services in the nature of development, production and post-production services in the fields of video and films
Scientific research; medical research; biotechnology research; biomedical research services; research and development in the field of biomedicine; computer software design and development; providing temporary use of online non-downloadable software development tools; providing online non-downloadable software for rare disease research; software as a service (SAAS) services featuring software for rare disease research; platform as a service (PAAS) featuring computer software platforms for rare disease research; providing temporary use of on-line non-downloadable open-source software for rare disease research; providing online non-downloadable software for connecting, supporting, and sharing information with patient-led organizations, patient advocacy organizations, researchers, clinicians, industry partners, patients, caregivers, families, academic institutions, healthcare institutions, and community members to improve the lives of people affected by rare disease; software as a service (SAAS) services featuring software for connecting, supporting, and sharing information with patient-led organizations, patient advocacy organizations, researchers, clinicians, industry partners, patients, caregivers, families, academic institutions, healthcare institutions, and community members to improve the lives of people affected by rare disease; platform as a service (PAAS) featuring computer software platforms for connecting, supporting, and sharing information with patient-led organizations, patient advocacy organizations, researchers, clinicians, industry partners, patients, caregivers, families, academic institutions, healthcare institutions, and community members to improve the lives of people affected by rare disease; providing a website featuring non-downloadable software using artificial intelligence (AI) for machine learning; providing online non-downloadable software using artificial intelligence (AI) for machine learning; software as a service (SAAS) services featuring software using artificial intelligence (AI) for machine learning
Regulatory compliance consulting in the field of rare diseases; providing regulatory compliance information in the field of rare diseases; providing an online computer database containing regulatory compliance information in the field of rare diseases
What has happened so far
Steps recorded by the USPTO, newest first.
- Application filing receipt mailed
- New application office supplied data entered
- New application entered
About RARE AS ONE
Who owns the trademark "RARE AS ONE"?
The USPTO trademark "RARE AS ONE" (application 50084749) is owned by Chan Zuckerberg Initiative, LLC.
What is the status of "RARE AS ONE"?
Its status at the USPTO is: under examination.
Get this data via the API
Everything on this page comes from the Signa API. Pull RARE AS ONE and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_01a06242-b906-75ab-bf25-4bbb2796f007
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_01a06242-b906-75ab-bf25-4bbb2796f007",
"object": "trademark",
"mark_text": "RARE AS ONE",
"status": {
"primary": "pending",
"stage": "examining"
},
"office_code": "US",
"application_number": "50084749",
"filing_date": "2026-09-01",
"nice_classes": [
9,
16,
35,
36,
41,
42,
45
],
"owners": [
{
"name": "Chan Zuckerberg Initiative, LLC",
"entity_id": "ent_019ebbba-1034-70b4-9091-94f34cf0b47f"
}
]
}